Profund Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-51,133
| Closed | -$948K | – | 1166 |
|
|
2023
Q3 | $948K | Sell |
51,133
-22,555
| -31% | -$255K | 0.05% | 297 |
|
|
2023
Q2 | $815K | Buy |
73,688
+25,860
| +54% | +$360K | 0.04% | 372 |
|
|
2023
Q1 | $642K | Buy |
+47,828
| New | +$828K | 0.04% | 424 |
|
|
2020
Q3 | – | Sell |
-6,051
| Closed | -$290K | – | 1014 |
|
|
2020
Q2 | $290K | Buy |
6,051
+871
| +17% | +$67.3K | 0.02% | 623 |
|
|
2020
Q1 | $326K | Sell |
5,180
-2,161
| -29% | -$194K | 0.02% | 466 |
|
|
2019
Q4 | $910K | Buy |
7,341
+932
| +15% | +$83.4K | 0.04% | 377 |
|
|
2019
Q3 | $425K | Buy |
6,409
+10
| +0.2% | +$672 | 0.02% | 676 |
|
|
2019
Q2 | $509K | Buy |
6,399
+285
| +5% | +$25.5K | 0.02% | 617 |
|
|
2019
Q1 | $684K | Buy |
6,114
+67
| +1% | +$7.32K | 0.03% | 493 |
|
|
2018
Q4 | $609K | Sell |
6,047
-1,441
| -19% | -$149K | 0.04% | 399 |
|
|
2018
Q3 | $946K | Buy |
7,488
+989
| +15% | +$105K | 0.04% | 422 |
|
|
2018
Q2 | $545K | Buy |
6,499
+559
| +9% | +$40.9K | 0.02% | 723 |
|
|
2018
Q1 | $365K | Sell |
5,940
-629
| -10% | -$37.9K | 0.01% | 1005 |
|
|
2017
Q4 | $384K | Sell |
6,569
-813
| -11% | -$51.3K | 0.01% | 972 |
|
|
2017
Q3 | $428K | Buy |
7,382
+589
| +9% | +$63.4K | 0.02% | 867 |
|
|
2017
Q2 | $822K | Sell |
6,793
-409
| -6% | -$47.4K | 0.04% | 472 |
|
|
2017
Q1 | $815K | Sell |
7,202
-598
| -8% | -$69.8K | 0.04% | 542 |
|
|
2016
Q4 | $847K | Sell |
7,800
-1,209
| -13% | -$144K | 0.04% | 531 |
|
|
2016
Q3 | $1.48M | Sell |
9,009
-437
| -5% | -$68.9K | 0.07% | 254 |
|
|
2016
Q2 | $1.35M | Sell |
9,446
-284
| -3% | -$41.4K | 0.07% | 263 |
|
|
2016
Q1 | $1.25M | Sell |
9,730
-2,383
| -20% | -$281K | 0.06% | 270 |
|
|
2015
Q4 | $1.81M | Buy |
12,113
+65
| +0.5% | +$11K | 0.09% | 185 |
|
|
2015
Q3 | $2M | Buy |
12,048
+1,812
| +18% | +$399K | 0.11% | 134 |
|
|
2015
Q2 | $2.47M | Buy |
10,236
+551
| +6% | +$147K | 0.1% | 146 |
|
|
2015
Q1 | $2.73M | Buy |
9,685
+1,623
| +20% | +$351K | 0.11% | 136 |
|
|
2014
Q4 | $1.26M | Buy |
8,062
+883
| +12% | +$163K | 0.05% | 344 |
|
|
2014
Q3 | $1.7M | Buy |
+7,179
| New | +$1.83M | 0.08% | 226 |
|
Profund Advisors's ICPT Position: Q4 2023 in Review
Profund Advisors sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 51,133 shares — an estimated $948K sold.
Profund Advisors first reported a position in ICPT in Q3 2014 and held it in 27 quarters. The position peaked at $2.73M in Q1 2015. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.
- Profund Advisors reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- Profund Advisors sold 51,133 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $948K.
- Profund Advisors first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2014 and held it in 27 quarters.
- Profund Advisors's Intercept Pharmaceuticals, Inc. position peaked at $2.73M in Q1 2015.
- 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.
Based on Profund Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.